Bioaminex does not sell products directly. Everything begins with lab work and a licensed physician. Please confirm you understand:
Peptide therapies may involve compounds that are prescription-only or investigational. Nothing here should be used without physician supervision and appropriate laboratory monitoring.
A copper peptide with genuinely solid evidence — for topical skin use specifically. The injectable, systemic claims are a different, less-proven story.
GHK-Cu is a useful example of a compound where the evidence is real but narrower than the marketing suggests. Here's the difference between what's well-studied and what's extrapolated.
GHK-Cu is a naturally occurring peptide that declines with age and plays a role in skin repair and wound healing. It's widely available in over-the-counter cosmetic products (marketed as "copper peptides") and, separately, as an injectable compounded product for broader systemic claims.
In skin, GHK-Cu appears to support collagen and elastin production and modulate the wound-healing process, which is the basis for its topical anti-aging use. Systemic/injectable use is based on extending that same wound-healing and tissue-remodeling logic to the whole body — a much bigger extrapolation that hasn't been established with the same rigor.
This is a genuine "tale of two evidence bases." Topically, GHK-Cu has real controlled human trial support: pooled data across a dozen studies and nearly 900 participants shows improved skin density, thickness, and wrinkle appearance with daily use over about 12 weeks, and a good safety record with minimal irritation and no evidence of systemic copper overload from topical use. For injectable, systemic use — hair growth, wound healing beyond skin, general anti-aging — the evidence is largely preclinical (animal and lab studies), not human trials.
Topically, side effects are minimal — mild redness or itching in a small percentage of users, no signal of toxicity in pooled safety data. Injectable/systemic use carries the general uncertainty of any compounded, non-FDA-reviewed injectable, and should go through the same lab-and-provider process as anything else on this page — not be assumed as safe as the topical version just because it's the "same" peptide.
If you're interested in GHK-Cu for skin — the topical evidence is genuinely solid. If you're interested in it for systemic, injectable anti-aging or hair-growth claims, you're relying on a much thinner, mostly preclinical evidence base, and that route should go through the same provider-supervised process as any other injectable peptide.
This article is for educational purposes only and is not medical advice. It does not establish a provider-patient relationship. FDA-approval status and clinical information are summarized in general terms and may change; consult a licensed healthcare provider and current prescribing information before making any medical decision. Bioaminex does not sell or dispense GHK-Cu or any medication.